All News about Abcellera Biologics Inc![]() ![]()
AbCellera Reports Full Year 2022 Business Results
February 21, 2023
Via Business Wire
![]()
Preview: AbCellera Biologics's Earnings
February 20, 2023
Via Benzinga
![]() ![]()
The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via Benzinga
![]() Via Business Wire
![]() ![]() ![]() ![]()
AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire
![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire
![]()
AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|